单位：[1]Graduate School, Beijing University of Chinese Medicine, Beijing, China [2]Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China
Capital's Funds for Health Improvement and Research [2018-2-4065]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81873396]; China-Japan Friendship Hospital
第一作者单位：[1]Graduate School, Beijing University of Chinese Medicine, Beijing, China [2]Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China
通讯作者：
推荐引用方式(GB/T 7714)：
Zheng Shu-Yue,Cui Hui-Juan.Body mass index: Another way to predict the efficacy of immune checkpoint inhibitors?[J].INTERNATIONAL IMMUNOPHARMACOLOGY.2020,84:doi:10.1016/j.intimp.2020.106523.
APA：
Zheng, Shu-Yue&Cui, Hui-Juan.(2020).Body mass index: Another way to predict the efficacy of immune checkpoint inhibitors?.INTERNATIONAL IMMUNOPHARMACOLOGY,84,
MLA：
Zheng, Shu-Yue,et al."Body mass index: Another way to predict the efficacy of immune checkpoint inhibitors?".INTERNATIONAL IMMUNOPHARMACOLOGY 84.(2020)
